Skip to main content
. 2017 Jun 1;28(5):e62. doi: 10.3802/jgo.2017.28.e62

Fig. 2.

Fig. 2

OS rate of uterine carcinosarcoma patients based on the presence of pathological necrosis (A) and more than 10% of the tumor being unenhanced on MRI (B). OS rate (C) and PFS rate (D) according to FIGO stage.

FIGO, International Federation of Gynecology and Obstetrics; MRI, magnetic resonance imaging; OS, overall survival; PFS, progression-free survival.